Published in J Biol Chem on July 24, 1998
Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection. J Virol (2004) 4.20
Pathways of antigen processing. Annu Rev Immunol (2013) 2.82
The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a "molecular ruler" mechanism. Proc Natl Acad Sci U S A (2005) 2.47
26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO J (2001) 2.09
Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance. Proc Natl Acad Sci U S A (2006) 1.91
Properties of the hybrid form of the 26S proteasome containing both 19S and PA28 complexes. EMBO J (2002) 1.68
Hepatitis C virus mutation affects proteasomal epitope processing. J Clin Invest (2004) 1.58
Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis. J Exp Med (2001) 1.50
The specificity of trimming of MHC class I-presented peptides in the endoplasmic reticulum. J Immunol (2009) 1.30
EpiJen: a server for multistep T cell epitope prediction. BMC Bioinformatics (2006) 1.26
Integrated modeling of the major events in the MHC class I antigen processing pathway. Protein Sci (2005) 1.23
Coping with loss of perfection in the MHC class I peptide repertoire. Curr Opin Immunol (2008) 1.21
Proteases in MHC class I presentation and cross-presentation. J Immunol (2010) 1.15
Retention of empty MHC class I molecules by tapasin is essential to reconstitute antigen presentation in invertebrate cells. EMBO J (1999) 1.13
A bicarbonate ion as a general base in the mechanism of peptide hydrolysis by dizinc leucine aminopeptidase. Proc Natl Acad Sci U S A (1999) 1.06
CCP1/Nna1 functions in protein turnover in mouse brain: Implications for cell death in Purkinje cell degeneration mice. FASEB J (2010) 1.06
Puromycin-sensitive aminopeptidase is the major peptidase responsible for digesting polyglutamine sequences released by proteasomes during protein degradation. EMBO J (2007) 1.04
Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes. J Exp Med (2000) 1.01
Differential HIV epitope processing in monocytes and CD4 T cells affects cytotoxic T lymphocyte recognition. J Infect Dis (2009) 1.00
Leucine aminopeptidase regulates defense and wound signaling in tomato downstream of jasmonic acid. Plant Cell (2009) 0.99
Aminopeptidase substrate preference affects HIV epitope presentation and predicts immune escape patterns in HIV-infected individuals. J Immunol (2012) 0.98
Role of immunoproteasome catalytic subunits in the immune response to hepatitis B virus. J Virol (2006) 0.98
Analysis of the role of tripeptidyl peptidase II in MHC class I antigen presentation in vivo. J Immunol (2009) 0.97
Puromycin-sensitive aminopeptidase protects against aggregation-prone proteins via autophagy. Hum Mol Genet (2010) 0.94
Processing sites are different in the generation of HLA-A2.1-restricted, T cell reactive tumor antigen epitopes and viral epitopes. Int J Immunopathol Pharmacol (2006) 0.93
Inhibitor-binding mode of homobelactosin C to proteasomes: new insights into class I MHC ligand generation. Proc Natl Acad Sci U S A (2006) 0.93
Two-substrate association with the 20S proteasome at single-molecule level. EMBO J (2004) 0.92
The cytoplasmic peptidase DPP9 is rate-limiting for degradation of proline-containing peptides. J Biol Chem (2009) 0.90
Expanded polyglutamine-containing N-terminal huntingtin fragments are entirely degraded by mammalian proteasomes. J Biol Chem (2013) 0.89
Measurement of protein tyrosine phosphatase activity in single cells by capillary electrophoresis. Anal Chem (2013) 0.87
Isolation and characterization of the neutral leucine aminopeptidase (LapN) of tomato. Plant Physiol (2003) 0.87
The immunoproteasome and viral infection: a complex regulator of inflammation. Front Microbiol (2015) 0.86
Carboxypeptidases in disease: insights from peptidomic studies. Proteomics Clin Appl (2014) 0.83
Role of endoplasmic reticulum aminopeptidases in health and disease: from infection to cancer. Int J Mol Sci (2012) 0.83
Different antigen-processing activities in dendritic cells, macrophages, and monocytes lead to uneven production of HIV epitopes and affect CTL recognition. J Immunol (2014) 0.82
PA28αβ: the enigmatic magic ring of the proteasome? Biomolecules (2014) 0.81
Targeting and localization of wound-inducible leucine aminopeptidase A in tomato leaves. Planta (2007) 0.81
β-Turn sequences promote stability of peptide substrates for kinases within the cytosolic environment. Analyst (2013) 0.80
A novel intracellular peptide derived from g1/s cyclin d2 induces cell death. J Biol Chem (2014) 0.79
Essential Role for an M17 Leucine Aminopeptidase in Encystation of Acanthamoeba castellanii. PLoS One (2015) 0.79
Distinct proteasome subpopulations in the alveolar space of patients with the acute respiratory distress syndrome. Mediators Inflamm (2012) 0.79
Impaired antigen processing and presentation machinery is associated with immunotolerant state in chronic hepatitis B virus infection. J Clin Immunol (2010) 0.79
Mechanisms of HIV protein degradation into epitopes: implications for vaccine design. Viruses (2014) 0.79
Characterizing the specificity and cooperation of aminopeptidases in the cytosol and endoplasmic reticulum during MHC class I antigen presentation. J Immunol (2010) 0.78
Enhanced expression of interferon-gamma-induced antigen-processing machinery components in a spontaneously occurring cancer. Neoplasia (2007) 0.76
Specific pools of endogenous peptides are present in gametophore, protonema, and protoplast cells of the moss Physcomitrella patens. BMC Plant Biol (2015) 0.76
Proteolysis of mature HIV-1 p6 Gag protein by the insulin-degrading enzyme (IDE) regulates virus replication in an Env-dependent manner. PLoS One (2017) 0.75
Varied Role of Ubiquitylation in Generating MHC Class I Peptide Ligands. J Immunol (2017) 0.75
Intracellular protein degradation in mammalian and bacterial cells: Part 2. Annu Rev Biochem (1976) 12.05
Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell (1994) 11.73
The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell (1994) 11.62
Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem (1996) 10.70
Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol (1998) 7.27
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A (2001) 6.76
Intracellular protein degradation in mammalian and bacterial cells. Annu Rev Biochem (1974) 6.05
Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell (1995) 5.61
Proteasome inhibitors: from research tools to drug candidates. Chem Biol (2001) 5.06
Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol (1997) 5.06
Production of abnormal proteins in E. coli stimulates transcription of lon and other heat shock genes. Cell (1985) 4.96
Effects of insulin, glucose, and amino acids on protein turnover in rat diaphragm. J Biol Chem (1975) 4.89
A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science (1995) 4.64
Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron (2001) 4.43
A soluble ATP-dependent proteolytic system responsible for the degradation of abnormal proteins in reticulocytes. Proc Natl Acad Sci U S A (1977) 4.17
Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature (1999) 4.13
The product of the lon (capR) gene in Escherichia coli is the ATP-dependent protease, protease La. Proc Natl Acad Sci U S A (1981) 4.10
Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu Rev Immunol (1999) 3.99
Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med (1996) 3.83
Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature (1993) 3.65
Selective inhibitors of the proteasome-dependent and vacuolar pathways of protein degradation in Saccharomyces cerevisiae. J Biol Chem (1996) 3.54
Degradation of abnormal proteins in Escherichia coli (protein breakdown-protein structure-mistranslation-amino acid analogs-puromycin). Proc Natl Acad Sci U S A (1972) 3.53
Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med (1983) 3.49
Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J Nutr (1999) 3.45
Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors. J Exp Med (1984) 3.36
Heat shock regulatory gene htpR influences rates of protein degradation and expression of the lon gene in Escherichia coli. Proc Natl Acad Sci U S A (1984) 3.33
Abnormal proteins serve as eukaryotic stress signals and trigger the activation of heat shock genes. Science (1986) 3.32
Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci U S A (1993) 3.27
Sequence of the lon gene in Escherichia coli. A heat-shock gene which encodes the ATP-dependent protease La. J Biol Chem (1988) 3.21
Proteolysis, proteasomes and antigen presentation. Nature (1992) 3.15
Subcellular distribution of various proteases in Escherichia coli. J Bacteriol (1982) 3.10
The axial channel of the proteasome core particle is gated by the Rpt2 ATPase and controls both substrate entry and product release. Mol Cell (2001) 2.91
Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors. Proc Natl Acad Sci U S A (1997) 2.81
Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance. J Biol Chem (1997) 2.80
Antigen processing and presentation by the class I major histocompatibility complex. Annu Rev Immunol (1996) 2.69
Arachidonic acid, prostaglandin E2 and F2 alpha influence rates of protein turnover in skeletal and cardiac muscle. J Biol Chem (1982) 2.59
Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J Biol Chem (1996) 2.51
Origin and possible significance of alanine production by skeletal muscle. J Biol Chem (1974) 2.49
Intermediate steps in the degradation of a specific abnormal protein in Escherichia coli. J Biol Chem (1977) 2.46
Effects of food deprivation on protein synthesis and degradation in rat skeletal muscles. Am J Physiol (1976) 2.42
Does leucine, leucyl-tRNA, or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscle? J Biol Chem (1982) 2.41
Protease Ti, a new ATP-dependent protease in Escherichia coli, contains protein-activated ATPase and proteolytic functions in distinct subunits. J Biol Chem (1988) 2.40
Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J Biol Chem (1997) 2.39
Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity (1994) 2.39
Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am J Physiol (1993) 2.33
Evidence for a role of cyclic AMP in neuromuscular transmission. Proc Natl Acad Sci U S A (1969) 2.32
The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation. J Biol Chem (1999) 2.29
Involvement of the chaperonin dnaK in the rapid degradation of a mutant protein in Escherichia coli. EMBO J (1992) 2.29
Protein turnover in skeletal muscle. II. Effects of denervation and cortisone on protein catabolism in skeletal muscle. J Biol Chem (1969) 2.27
What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? Curr Opin Clin Nutr Metab Care (2001) 2.18
Work-induced growth of skeletal muscle in normal and hypophysectomized rats. Am J Physiol (1967) 2.15
Identity of the 19S 'prosome' particle with the large multifunctional protease complex of mammalian cells (the proteasome). Nature (1988) 2.15
Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy. J Biol Chem (1990) 2.14
Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. Biochem J (1995) 2.11
A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation. Nature (1993) 2.11
Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. Proc Natl Acad Sci U S A (2000) 2.10
The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors. Proc Natl Acad Sci U S A (1987) 2.10
Protein degradation is stimulated by ATP in extracts of Escherichia coli. J Biol Chem (1979) 2.09
26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO J (2001) 2.09
Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. Proc Natl Acad Sci U S A (1994) 2.08
Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. Proc Natl Acad Sci U S A (1997) 2.08
The proteasome (multicatalytic protease) is a component of the 1500-kDa proteolytic complex which degrades ubiquitin-conjugated proteins. J Biol Chem (1990) 2.06
Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nat Med (1995) 2.06
Degradation of abnormal proteins in Escherichia coli. Formation of protein inclusions in cells exposed to amino acid analogs. J Biol Chem (1975) 2.03
Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Am J Physiol (1995) 1.98
Effects of protease inhibitors on protein breakdown in Escherichia coli. J Biol Chem (1972) 1.97
Trehalose accumulation during cellular stress protects cells and cellular proteins from damage by oxygen radicals. J Biol Chem (2001) 1.97
HslV-HslU: A novel ATP-dependent protease complex in Escherichia coli related to the eukaryotic proteasome. Proc Natl Acad Sci U S A (1996) 1.94
Leupeptin, a protease inhibitor, decreases protein degradation in normal and diseased muscles. Science (1978) 1.93
Demonstration of an ATP-dependent, vanadate-sensitive endoprotease in the matrix of rat liver mitochondria. J Biol Chem (1982) 1.92
The heat-shock protein ClpB in Escherichia coli is a protein-activated ATPase. J Biol Chem (1992) 1.92
Inhibition of antigen-specific T lymphocyte activation by structurally related Ir gene-controlled polymers. Evidence of specific competition for accessory cell antigen presentation. J Exp Med (1983) 1.92
Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. J Clin Invest (1997) 1.90
The degradation of apolipoprotein B100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70. J Biol Chem (1997) 1.87
Escherichia coli contains a soluble ATP-dependent protease (Ti) distinct from protease La. Proc Natl Acad Sci U S A (1987) 1.87
A high molecular weight protease in the cytosol of rat liver. I. Purification, enzymological properties, and tissue distribution. J Biol Chem (1986) 1.86
P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol (2001) 1.86
Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. J Clin Invest (1994) 1.83
A set of endoplasmic reticulum proteins possessing properties of molecular chaperones includes Ca(2+)-binding proteins and members of the thioredoxin superfamily. J Biol Chem (1994) 1.83
Proteins are unfolded on the surface of the ATPase ring before transport into the proteasome. Mol Cell (2001) 1.81
The ATP-dependent HslVU protease from Escherichia coli is a four-ring structure resembling the proteasome. Nat Struct Biol (1997) 1.81
Further evidence for the involvement of charged tRNA and guanosine tetraphosphate in the control of protein degradation in Escherichia coli. J Biol Chem (1978) 1.78
A role of aminoacyl-tRNA in the regulation of protein breakdown in Escherichia coli. Proc Natl Acad Sci U S A (1971) 1.77
Structural characterization of the TAP molecule: a phosphatidylinositol-linked glycoprotein distinct from the T cell receptor/T3 complex and Thy-1. Cell (1986) 1.77
Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A (1996) 1.76
Energy requirement for degradation of tumor-associated protein p53. Mol Cell Biol (1984) 1.73
Proteases in Escherichia coli. Methods Enzymol (1981) 1.72
Leucine degradation in cell-free extracts of skeletal muscle. Biochem J (1979) 1.71
Oxidation of leucine by rat skeletal muscle. Am J Physiol (1972) 1.70
Regulation and significance of amino acid metabolism in skeletal muscle. Fed Proc (1978) 1.70
The stimulation of protein degradation in muscle by Ca2+ is mediated by prostaglandin E2 and does not require the calcium-activated protease. J Biol Chem (1982) 1.70
Involvement of the molecular chaperone Ydj1 in the ubiquitin-dependent degradation of short-lived and abnormal proteins in Saccharomyces cerevisiae. Mol Cell Biol (1996) 1.69
Oxidation of amino acids by diaphragms from fed and fasted rats. Am J Physiol (1972) 1.67
Hormonal regulation of protein degradation and synthesis in skeletal muscle. Fed Proc (1980) 1.65